程晓东附属妇产科医院临床医学妇科肿瘤个人简介:程晓东浙江大学医学院附属妇产科医院副院长主任医师，医学博士，博士生导师中华医学会妇科肿瘤学分会委员浙江省医学会妇科肿瘤学分会候任主任委员中国教育国际交流协会国际医学教育分会学科组专家浙江省医学会医学教育学分会委员《浙江医学教育》编辑委员会委员教育及工作经历：1992年，浙江大学，临床医学，学士学位1998年，浙江大学，临床医学，硕士学位2006年，任浙江大学医学院附属妇产科医院科教科科长2008年，浙江大学，临床医学，博士学位2011年，主任医师2013年，任浙江大学医学院附属妇产科医院院长助理2016年，任浙江大学医学院附属妇产科医院副院长简介：        程晓东老师热心教育和教学研究，工作认真负责，教学责任心强，是教育部来华留学英语授课品牌课程——浙江大学《妇产科学》课程负责人，中华医学会妇科肿瘤学分会委员、浙江省医学会妇科肿瘤学分会候任主任委员、中国教育国际交流协会国际医学教育分会学科组专家、浙江省医学会医学教育学分会委员、《浙江医学教育》编辑委员会委员等。教学方法灵活、形式多样，教学手段丰富、曾获浙江省教学成果二等奖1项，浙江大学教学成果奖3项，发表教学论文10余篇，多次获得“先进工作者”、“三育人标兵”、“先进个人”等荣誉。        近年来程晓东老师已发表SCI 论文数十篇，主持国家自然科学基金等课题4 项，获2010 年浙江省科学技术奖二等奖、2015 年浙江省医药卫生科技奖，2017年高等学校科学研究优秀成果奖科技进步奖一等奖。教学与课程:授课情况：现代妇产科学（研究生课程）Obstetrics & Gynecology（留学生课程）重要疾病临床与研究3（求是生物班）临床技能（甲）（本科生课程）妇产科学（甲）（本科生课程）主持或主要参加教学建设改革项目情况：教育部来华留学英语授课品牌课程（主持1/18）国家级精品资源共享课(参与2/16)国家精品课程（参与2/16）妇产科学临床技能案例学习模式研究（主持1/5）教学奖励：1、“以需求为导向，以学生为中心的《妇产科学》立体化教材建设（教材）”，2016 年， 浙江省教学成果二等奖， 排名 3/52、“《妇产科学》立体化教材的研究与建设” ， 2016年， 浙江大学教学成果一等奖，排名 3/53、“《妇产科学》系列教材建设” ，2014 年， 浙江大学医学院教学成果一等奖，排 名 3/44、浙江大学第七届“三育人”管理服务标兵，2014年5、2013-2014年度浙江省教育系统“三育人”先进个人 ，2014年6、浙江大学医学院先进工作者，2015年参编教材：1、参编《 Obstetrics & Gynecology》第 1版， 清华大学出版社， 2017年 3月出版2、参编 《医学生临床技能操作规范》第1版，浙江大学出版，2016年 1月出版3、参编 《宫内节育器放置术》、《宫内节育器取出术》、《分段诊断性刮宫术》、《经阴道后穹窿穿刺术》等妇产科学教学视频，浙江大学出版社，2016年1月出版研究与成果:论文：1. Xiaodong Cheng Weiguo Lv Feng Ye Xiaoyun Wan Xing Xie. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. J Exp Clin Cancer Res 2009 28(1): 91-962. Jing Ye Xiaodong Cheng Xiaojing Chen Feng Ye Weiguo Lu Xing Xie. Prevalence and risk profile of cervical human papillomavirus infection in Zhejiang Province southeast China: a population-based study.Virology Journal 2010 7: 66-723. Jing YeXiaodong Cheng Xiaojing Chen Feng Ye Weiguo Lu Xing Xie. Short-term type-specific HPV persistence and its predictors in an asymptomatic general female population in Zhejiang China. Int J Gyencol Obstet 2010 110(3): 217-222.4. Yan LiLi Yeng Ye Xiaodong Cheng Ying Hu Caiyun Zhou Weiguo Lu Xing Xie. Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer. Eur J Cancer 2010 46(11): 2104-2118.5. Huaizeng Chen Dafeng Ye Xing Xie Weiguo Lu Changkun Zhu Xiaodong Cheng. PTEN Promoter Methylation and Protein Expression in Normal Early Placentas and Hydatidiform Moles. J Soc Gynecol Investig 2005 12 214-217.6. Zeng WJ Li Y Fei HL Cheng XD Ye F Lv WG et al. The value of p16ink4a expression by fluorescence in situ hybridization in triage for high risk HPV positive in cervical cancer screening. Gynecol Oncol 2011; 120: 84-88.7. Ma YY Cheng XD Zhou CY Qiu LQ Chen XD Lü WG Xie X. Value of P16 expression in the triage of liquid-based cervical cytology with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Chin Med J (Engl) 2011 124(16):2 443-2447. (Coresponding Author)8. Li BH Zhou JS Ye F Cheng XD Zhou CY Lu WG Xie X. Reduced miR-100 expression in cervical cancer and precursors and its arcinogenic effect through targeting PLK1 protein. Eur J Cancer 2011 47(14): 2166-2174.9. Liu J Lu WG Ye F Cheng XD Hong D Hu Y Chen HZ Xie X. Hes1/Hes5 gene inhibits differentiation via down-regulating Hash1 and promotes proliferation in cervical carcinoma cells. Int J Gynecol Cancer2010 20(7): 1109-1116.10.XD Cheng B ChengX WanW LuX Xie. Outcomes of conservative surgery in early epithelial ovarian carcinoma. Eur J Gynaec Oncol 2012 XXXIII 93-95.11.Cheng XDLv WGYe FChen HZXie X. The evaluation of the value of locally neoadjuvant chemotherapy for advanced cervical cancer. The Chinese journal of obstetrics and gynecology 2006; 41(2): 95-98.12.Cheng XDLv WGWan XYChen XDXie X. The clinical analysis of six cases of epithelioid sertoli cell tumor. The Chinese journal of obstetrics and gynecology 2008; 43(4): 281-285.13.Cheng XD Xie X. The Progress of the clinical application of Locally neoadjuvant chemotherapy of advanced cervical cancer. Chinese medical journal 2005; 85(30): 2154-2156.14.Cheng XD Xie X. Recurrent ovarian cancer and its treatment outside the abdominal cavity. Chinese journal of practical gynecology and obstetrics 2005; 21(7): 399-40111.15.Cheng XD Xie X. The epidemiology of HPV infection in the female reproductive tract.  Practical journal of obstetrics and gynecology 2004; 20(2): 65-66.16.Cheng XD Lv WG Xie X et al. The analysis of platinum drugs application in recurrent epithelial ovarian carcinoma in the near future therapeutic effect and its related factors. The Chinese journal of obstetrics and gynecology 2003; 30(11): 113-116.17.Cheng XD Xie X. Neoadjuvant chemotherapy of cervical cancer. Practical tumor magazine 2008; 23(5): 397-400.18.Feng Y Wang XY Cheng YF Cheng XD Lv WG Xie X. The study of the relationship between the load of high risk HPV and cervical cancer and precancerous lesion. Current Advances in obstetrics and gynecology 2008; 17(10): 730-732.19.Chen WB Lv WG Xie X Cheng XD Zheng XD Su XF. The relationship between the expression of XPC、ERCC1 in locally advanced cervical cancer cells and the curative effect of neoadjuvant chemotherapy. Journal of wenzhou medical college 2008; 38(3): 248-252.20.Shen YM Lv WG Ye F Cheng XD Xie X. The clinical evaluation of electric heating circle ring cut method in the diagnosis and the treatment of cervical carcinoma in situ. Current Advances in obstetrics and gynecology 2006; 15(7): 505-507.21.Zhou J Peng C Li B Wang F Zhou C Hong D Ye F Cheng X Lü W Xie X. Transcriptional gene silencing of HPV 16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.  Gynecol Oncol. 2012 Feb; 124(2): 296-302.22.J Qin X ChengX ChenX ZhangW LuX Xie.Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. Ultrasound Obstet Gynecol 2012 39: 226-234.23.Shao YPCheng XDWan XY. The expression of GRIM-19 protein in ovarian epithelial carcinoma tissue and its clinical significance. The Chinese journal of obstetrics and gynecology 2012 10: 751-755.24.Wang P Cheng XD Xie X. Mitochondrial protein NDUFS3 and tumor. International journal of oncology 2012 39(9): 647-650.25.Cheng Xiaodong; Feng Yan; Wang Xinyu; Wan Xiaoyun; Xie Xing; Lu Weiguo. The effectiveness of conization treatment for post-menopausal women with high-grade cervical intraepithelial neoplasia. EXPERIMENTAL AND THERAPEUTIC MEDICINE 2013 5 (1):185-188. (Coresponding Author)26.Sima Ni; Cheng Xiaodong; Ye Feng; Xie Xing; Lu Weiguo. The Overexpression of Scaffolding Protein NEDD9 Promotes Migration and Invasion in Cervical Cancer via Tyrosine Phosphorylated FAK and SRC. PLOS ONE 2013 8 (9):e74594. (Co-First Author)27. P WangXD ChengZQ FuCYZhouWG LuX Xie. Reduced expression of NDUFS3 and its clinical significance in serous ovarian cancer. Int J Gynecol Cancer 2013 23(4):622-629 (Co-First Author)28.Jiao Jie; Huang Lu; Ye Feng; Shi MinFeng; Cheng XiaoDong; Wang XinYu; Hu  DongXiao; Xie Xing; Lv WeiGuo. Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells. ONCOTARGETS AND THERAPY 2013 6: 667-677.29.Shen Y; Wang P; Li Y; Ye F; Wang F; Wan X; Cheng X; Lu W; Xie X. MiR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. BRITISH JOURNAL OF CANCER 2013 109(1):92-99.30.Qifang Tian yang li fenfen wang Ying Li Junfen Xu Yuanming Shen feng ye Xinyu Wang Xiaodong Cheng Yaxia Chen xiaoyun wan Weiguo Lu and Xing Xie. MicroRNA detection in cervical exfoliated cells as a triage for Human Papillomavirus positive women. The Journal of the National Cancer Institute 201431.Shi Y1 Li L Hu Z Li S Wang S Liu J Wu C He L Zhou J Li Z Hu T Chen Y Jia Y Wang S Wu L Cheng X Yang Z Yang R Li X Huang K Zhang Q Zhou H Tang F Chen Z Shen J Jiang J Ding H Xing H Zhang S Qu P Song X Lin Z Deng D Xi L Lv W Han X Tao G Yan L Han Z Li Z Miao X Pan S Shen Y Wang H Liu D Gong E Li Z Zhou L Luan X Wang C Song Q Wu S Xu H Shen J Qiang F Ma G Liu L Chen X Liu J Wu J Shen Y Wen Y Chu M Yu J Hu X Fan Y He H Jiang Y Lei Z Liu C Chen J Zhang Y Yi C Chen S Li W Wang D Wang Z Di W Shen K Lin D Shen H Feng Y Xie X Ma D. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet 2013 45(8): 918-922.32. Li S Hu T Chen Y Zhou H Li X Cheng X Yang R Wang S Xie X Ma D. Adjuvant chemotherapy a valuable alternative option in selected patients with cervical cancer. Plos one 2013 8(9): e73837.33. Hu T Li S Chen Y Shen J Li X Huang K Yang R Wu L Chen Z Jia Y Wang S Cheng X Han X Lin Z Xing H Qu P Cai H Song X Tian X Xu H Xu J Zhang Q Xi L Deng D Wang H Wang S Lv W Wang C Xie X Ma D. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria. Eur J Cancer 2012 48(15): 2353-2360.34.Xiaoming Pan Xiangrong Xu Lili Huang Xiaodong Cheng. The challenges and solutions of education in the clinical practice of obstetrics and gynecology of international students. Northwest Medical Education 2015 23(2): 333-34435.Yinju Wang Xiangrong Xu Zhenzhen Fu Xiaoming Zhu Weiguo Lv Xiaodong Cheng. Current situation and development strategy of scientific research in college affiliated special hospital. Zhejiang medical 2015 37（15）: 1327-1329.36.Wei Zheng Xiangrong Xu Xiaodong Cheng. The impact of environmental health factors on obstetrics and gynecology teaching. Education and Teaching Forum 2015 29: 120-121.37.Zhang SF Wang XY Fu ZQ Peng QH Zhang JY Ye F Fu YF Zhou CY Lu WG Cheng XD Xie X. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer. Autophagy. 2015 Jan 21:0.38.Lu Huang Shanshan Xu Dongxiao Hu Weiguo Lu Xing Xie Xiaodong Cheng. IQGAP1 is involved in enhanced aggressive behavior of epithelial ovarian cancer stem cell-like cells during differentiation. Int J Gyencol Cancer 2015 25(4): 559-565. (Coresponding Author)39.Fu Y Chen C Feng S Cheng X Wang X Xie X Lü W. Residual disease and risk factors in patients with high-grade cervical intraepithelial neoplasia and positive margins after initial conization. Ther Clin Risk Manag. 2015 11:851-6.40.Xiao Li Qianqian Pan Xiaoyun Wan Yuyan Mao Weiguo Lu Xing Xie and Xiaodong Cheng  (Coresponding Author). Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma. BMC Cancer 2015 15:509-41.Xu J Fang Y Wang X Wang F Tian Q Li Y Xie X Cheng X Lu W. (Co-coresponding Author) CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis. Oncotarget 2016 7(21):31520-31533.(IF:)42.Baohua LiHaiyan ShiFenfen WangDie HongWeiguo LvXing XieXiaodong Cheng. (Coresponding Author) Expression of E-P- and N-Cadherin and its clinical significance in cervical squamous cell carcinoma and precancerous lesion.Plos one2016.Doi:10.1371/journal.pone.0155910.43.Baohua Li Haiyan ShiFenfen WangDie HongWeiguo LvXing XieXiaodong Cheng. (Coresponding Author) Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8. Plos one 2016 11(9):e016237844.Die HongJia LiuYing HuXiaonan LuBaohua LiYang LiDongxiao HuWeiguo LuXing XieXiaodong Cheng. (Coresponding Author) Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16. BMC Cancer 2017 17:136.主持的科研项目：1、国家基金;TRP14/Beclin1/自噬通路在调控卵巢癌对紫杉醇敏感性中的作用 课题编号：81372789，课题起止时间：2014-2017，资助金额：65万元人民币。线粒体复合物NDUFS3在上皮性卵巢癌发生中的作用及其机制研究，课题编号：81072119，课题起止时间：2011-2013，资助金额：34万元人民币。2、国家重点研发项目：构建基于组学特征谱的新一代宫颈癌早期精准诊疗策略 ，课题编号： 2016YFC0902902 ，课题起止时间：2016-2018，资助金额：80万元人民币。3、浙江省科研项目：细胞自噬在调控卵巢癌对紫杉醇敏感性中的作用与机制研究，课题编号： LZ14H160001，课题起止时间：2014-2017，资助金额：40万元人民币。线粒体复合物NDUFS3在上皮性卵巢癌发生中的作用及其机制研究，课题编号： Y2100377 ，课题起止时间：2010-2013，资助金额：80万元人民币。中国汉族妇女葡萄胎发生与恶性变的遗传易感性研究，课题编号： 2012C24029 ，课题起止时间：2012-2015，资助金额：20万元人民币。GRIM-19基因表达与上皮性卵巢癌发生关系的研究，课题编号： 2010KKA130 ，课题起止时间：2010-2012，资助金额：3万元人民币。